SG94355A1 - Human telomerase catalytic subunit - Google Patents
Human telomerase catalytic subunitInfo
- Publication number
- SG94355A1 SG94355A1 SG200101834A SG200101834A SG94355A1 SG 94355 A1 SG94355 A1 SG 94355A1 SG 200101834 A SG200101834 A SG 200101834A SG 200101834 A SG200101834 A SG 200101834A SG 94355 A1 SG94355 A1 SG 94355A1
- Authority
- SG
- Singapore
- Prior art keywords
- human telomerase
- catalytic subunit
- telomerase catalytic
- human
- treatment
- Prior art date
Links
- 101000655352 Homo sapiens Telomerase reverse transcriptase Proteins 0.000 title abstract 3
- 238000011282 treatment Methods 0.000 abstract 3
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 102000002067 Protein Subunits Human genes 0.000 abstract 1
- 108010001267 Protein Subunits Proteins 0.000 abstract 1
- 108010017842 Telomerase Proteins 0.000 abstract 1
- 230000003197 catalytic effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 102000040430 polynucleotide Human genes 0.000 abstract 1
- 108091033319 polynucleotide Proteins 0.000 abstract 1
- 239000002157 polynucleotide Substances 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 238000004393 prognosis Methods 0.000 abstract 1
- 230000002062 proliferating effect Effects 0.000 abstract 1
- 238000012216 screening Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1137—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1241—Nucleotidyltransferases (2.7.7)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1241—Nucleotidyltransferases (2.7.7)
- C12N9/1276—RNA-directed DNA polymerase (2.7.7.49), i.e. reverse transcriptase or telomerase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
- C12Y207/07—Nucleotidyltransferases (2.7.7)
- C12Y207/07049—RNA-directed DNA polymerase (2.7.7.49), i.e. telomerase or reverse-transcriptase
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/15—Nucleic acids forming more than 2 strands, e.g. TFOs
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/31—Chemical structure of the backbone
- C12N2310/315—Phosphorothioates
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/828—Cancer
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Immunology (AREA)
- Neurology (AREA)
- Hematology (AREA)
- Plant Pathology (AREA)
- Neurosurgery (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Reproductive Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US72464396A | 1996-10-01 | 1996-10-01 | |
US84441997A | 1997-04-18 | 1997-04-18 | |
US84601797A | 1997-04-25 | 1997-04-25 | |
US08/851,843 US6093809A (en) | 1996-10-01 | 1997-05-06 | Telomerase |
US08/854,050 US6261836B1 (en) | 1996-10-01 | 1997-05-09 | Telomerase |
US91550397A | 1997-08-14 | 1997-08-14 | |
US91131297A | 1997-08-14 | 1997-08-14 | |
US08/912,951 US6475789B1 (en) | 1996-10-01 | 1997-08-14 | Human telomerase catalytic subunit: diagnostic and therapeutic methods |
Publications (1)
Publication Number | Publication Date |
---|---|
SG94355A1 true SG94355A1 (en) | 2003-02-18 |
Family
ID=27575511
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG200101834A SG94355A1 (en) | 1996-10-01 | 1997-10-01 | Human telomerase catalytic subunit |
Country Status (21)
Country | Link |
---|---|
US (4) | US6166178A (fr) |
EP (6) | EP0954585B1 (fr) |
JP (7) | JP2001523947A (fr) |
KR (2) | KR20000048820A (fr) |
CN (3) | CN1291231B (fr) |
AT (3) | ATE245194T1 (fr) |
AU (2) | AU4803697A (fr) |
BR (3) | BR9712254A (fr) |
CA (3) | CA2645721C (fr) |
DE (5) | DE69723531T3 (fr) |
EA (2) | EA199900349A1 (fr) |
ES (1) | ES2205132T5 (fr) |
FI (1) | FI990655A0 (fr) |
FR (1) | FR2757177A1 (fr) |
GB (2) | GB2317891C (fr) |
HK (1) | HK1156967A1 (fr) |
IL (2) | IL129222A0 (fr) |
NO (2) | NO319982B1 (fr) |
NZ (1) | NZ334709A (fr) |
SG (1) | SG94355A1 (fr) |
WO (2) | WO1998014593A2 (fr) |
Families Citing this family (171)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5958680A (en) | 1994-07-07 | 1999-09-28 | Geron Corporation | Mammalian telomerase |
US6517834B1 (en) | 1995-08-04 | 2003-02-11 | Geron Corporation | Purified telomerase |
US6545133B1 (en) | 1995-08-04 | 2003-04-08 | Geron Corporation | Methods for purifying telomerase |
DE19681033D2 (de) | 1995-11-16 | 1999-03-18 | Michael W Dahm | Verfahren zur Quantifizierung von Tumorzellen in einer Körperflüssigkeit und dazu geeignete Testkits |
US6881571B1 (en) * | 1998-03-11 | 2005-04-19 | Exonhit Therapeutics S.A. | Qualitative differential screening |
US6607898B1 (en) | 1996-03-26 | 2003-08-19 | Oncomedx, Inc. | Method for detection of hTR and hTERT telomerase-associated RNA in plasma or serum |
US6093809A (en) | 1996-10-01 | 2000-07-25 | University Technology Corporation | Telomerase |
ATE245194T1 (de) * | 1996-10-01 | 2003-08-15 | Geron Corp | Katalytische untereinheit der menschlichen telomerase |
US6610839B1 (en) | 1997-08-14 | 2003-08-26 | Geron Corporation | Promoter for telomerase reverse transcriptase |
US6475789B1 (en) | 1996-10-01 | 2002-11-05 | University Technology Corporation | Human telomerase catalytic subunit: diagnostic and therapeutic methods |
US6444650B1 (en) * | 1996-10-01 | 2002-09-03 | Geron Corporation | Antisense compositions for detecting and inhibiting telomerase reverse transcriptase |
US6808880B2 (en) | 1996-10-01 | 2004-10-26 | Geron Corporation | Method for detecting polynucleotides encoding telomerase |
US7585622B1 (en) | 1996-10-01 | 2009-09-08 | Geron Corporation | Increasing the proliferative capacity of cells using telomerase reverse transcriptase |
US6261836B1 (en) * | 1996-10-01 | 2001-07-17 | Geron Corporation | Telomerase |
US6777203B1 (en) | 1997-11-19 | 2004-08-17 | Geron Corporation | Telomerase promoter driving expression of therapeutic gene sequences |
US7390891B1 (en) | 1996-11-15 | 2008-06-24 | Amgen Inc. | Polynucleotides encoding a telomerase component TP2 |
EP0942991A2 (fr) * | 1996-11-26 | 1999-09-22 | Baylor College Of Medicine | Identification d'inhibiteurs empechant l'acces de la telomerase aux terminaisons chromosomiques |
WO1998037181A2 (fr) * | 1997-02-20 | 1998-08-27 | Whitehead Institute For Biomedical Research | Gene de sous-unite catalytique de telomerase et proteine codee |
US7413864B2 (en) | 1997-04-18 | 2008-08-19 | Geron Corporation | Treating cancer using a telomerase vaccine |
US20050013825A1 (en) * | 1997-04-18 | 2005-01-20 | Geron Corporation | Vaccine containing the catalytic subunit of telomerase for treating cancer |
US7622549B2 (en) | 1997-04-18 | 2009-11-24 | Geron Corporation | Human telomerase reverse transcriptase polypeptides |
AU745420B2 (en) * | 1997-06-20 | 2002-03-21 | Bayer Aktiengesellschaft | Human catalytic telomerase sub-unit and its diagnostic and therapeutic use |
IL133830A0 (en) * | 1997-07-01 | 2001-04-30 | Cambia Biosystems Llc | Vertebrate tolomerase genes and proteins and uses thereof |
EP1571215A3 (fr) * | 1997-07-01 | 2007-10-31 | Cambia Biosystems LLC | Gènes et protéines de télomérases de vertèbres et leurs utilisations |
WO2000046355A2 (fr) * | 1999-02-04 | 2000-08-10 | Geron Corporation | Sequences de regulation transcriptionnelle de la transcriptase inverse de la telomerase |
US7378244B2 (en) | 1997-10-01 | 2008-05-27 | Geron Corporation | Telomerase promoters sequences for screening telomerase modulators |
AU1606999A (en) * | 1997-11-26 | 1999-06-15 | Albert Einstein College Of Medicine Of Yeshiva University | Mouse telomerase reverse transcriptase |
DE19757984A1 (de) * | 1997-12-24 | 1999-07-01 | Bayer Ag | Regulatorische DNA-Sequenzen aus der 5'-Region vom Gen der humanen katalytischen Telomerase-Untereinheit udn deren diagnostische und therapeutische Verwendung |
DE19804372A1 (de) | 1998-02-04 | 1999-08-05 | Michael W Dr Dr Dahm | Verfahren zur quantitativen Bestimmung von Tumorzellen in einer Körperflüssigkeit und dazu geeignete Testkits |
US6639057B1 (en) | 1998-03-26 | 2003-10-28 | Kyowa Hakko Kogyo Co., Ltd. | Monoclonal antibody against human telomerase catalytic subunit |
JP2002509716A (ja) | 1998-03-31 | 2002-04-02 | ユニバーシティ テクノロジー コーポレイション | テロメラーゼ抗原に対する免疫応答を惹起するための方法および組成物 |
US6337200B1 (en) * | 1998-03-31 | 2002-01-08 | Geron Corporation | Human telomerase catalytic subunit variants |
US7402307B2 (en) | 1998-03-31 | 2008-07-22 | Geron Corporation | Method for identifying and killing cancer cells |
US20030105315A1 (en) * | 1998-04-09 | 2003-06-05 | Metagen Pharmaceuticals Gmbh | Human nucleic acid sequences from ovarian tumor tissue |
US7030211B1 (en) | 1998-07-08 | 2006-04-18 | Gemvax As | Antigenic peptides derived from telomerase |
US6900049B2 (en) | 1998-09-10 | 2005-05-31 | Cell Genesys, Inc. | Adenovirus vectors containing cell status-specific response elements and methods of use thereof |
US6667176B1 (en) | 2000-01-11 | 2003-12-23 | Geron Corporation | cDNA libraries reflecting gene expression during growth and differentiation of human pluripotent stem cells |
DE69934426T2 (de) | 1998-10-29 | 2007-10-04 | Whitehead Institute For Biomedical Research, Cambridge | KREBSIMMUNTHERAPIE UND KREBSDIAGNOSE UNTER VERWENDUNG UNIVERSELLER TUMORASSOZIIERTER ANTIGENE EINSCHLIESSLICH hTERT |
GB9900298D0 (en) * | 1999-01-07 | 1999-02-24 | Medical Res Council | Optical sorting method |
DE10003356A1 (de) * | 1999-01-22 | 2000-07-27 | Humboldt Uni Zu Berlin Univers | Gegen die katalytische Untereinheit der humanen Telomerase (hTERT)gerichtete Ribozyme |
US8114850B2 (en) | 1999-04-08 | 2012-02-14 | Advanced Cancer Therapeutics, Llc | Antiproliferative activity of G-rich oligonucleotides and method of using same to bind to nucleolin |
US7960540B2 (en) | 1999-04-08 | 2011-06-14 | Advanced Cancer Therapeutics, Llc | Antiproliferative activity of G-rich oligonucleotides and method of using same to bind to nucleolin |
ES2296615T3 (es) | 1999-04-08 | 2008-05-01 | Antisoma Research Limited | Actividad antiproliferativa de oligonucleotidos ricos en g y procedimiento de uso de los mismos para su union a la nucleolina. |
EP1171612A2 (fr) * | 1999-04-09 | 2002-01-16 | Biomira, Inc. | Vaccin anticancereux specifique de la telomerase |
US6358739B1 (en) * | 1999-04-12 | 2002-03-19 | Modex Therapeutiques, S.A. | Transiently immortalized cells |
DE19916929A1 (de) * | 1999-04-15 | 2000-10-19 | Bayer Ag | Ein automatisierbarer Schnelltest zum Nachweis von Krebserkrankungen auf der Basis von Telomerase(hTC) mRNA mit spezifischen Primern und Sonden |
US6995145B1 (en) | 1999-06-04 | 2006-02-07 | Au Jessie L-S | Methods and compositions for modulating drug activity through telomere damage |
US20050255596A1 (en) * | 1999-09-07 | 2005-11-17 | West Michael D | Methods of repairing tandemly repeated DNA sequences and extending cell life-span nuclear transfer |
ES2302701T3 (es) | 1999-09-10 | 2008-08-01 | Geron Corporation | N3'-p5' tiofosforamidatos oligonucleotidicos: su sintesis y uso. |
FR2798673B1 (fr) * | 1999-09-16 | 2004-05-28 | Exonhit Therapeutics Sa | Methodes et compositions pour la detection d'evenements pathologiques |
US6399384B1 (en) | 1999-09-17 | 2002-06-04 | Reneuron Limited | Conditional immortalization of cells |
AU1309101A (en) * | 1999-11-16 | 2001-05-30 | Kyowa Hakko Kogyo Co. Ltd. | Method of searching for substance inhibiting binding between telomerase subunits |
GB9927353D0 (en) * | 1999-11-19 | 2000-01-19 | Cantab Pharma Res | Virus preparation and use |
US6664046B1 (en) * | 1999-12-16 | 2003-12-16 | Roche Molecular Systems, Inc. | Quantitation of hTERT mRNA expression |
KR20010096991A (ko) * | 2000-04-19 | 2001-11-08 | 임정빈 | 텔로머레이즈의 프로모터에 특정하게 결합하는더블유티이1 절편, 그 유전자, 발현벡터 및 그것을 이용한세포성장 억제 방법 |
US6458589B1 (en) | 2000-04-27 | 2002-10-01 | Geron Corporation | Hepatocyte lineage cells derived from pluripotent stem cells |
IT1318504B1 (it) * | 2000-05-08 | 2003-08-27 | Talent Srl | Metodo e apparecchiatura per la diagnosi precoce di tumori vescicalisu campioni di urina. |
US6331399B1 (en) | 2000-05-16 | 2001-12-18 | Isis Pharmaceuticals, Inc. | Antisense inhibition of tert expression |
US6492171B2 (en) | 2000-05-16 | 2002-12-10 | Isis Pharmaceuticals, Inc. | Antisense modulation of TERT expression |
US7250294B2 (en) | 2000-05-17 | 2007-07-31 | Geron Corporation | Screening small molecule drugs using neural cells differentiated from human embryonic stem cells |
EP1158055A1 (fr) | 2000-05-26 | 2001-11-28 | Xu Qi University of Teaxs Laboratoire de Leucémie Chen | Méthode pour le diagnostic de cancers |
US7078491B1 (en) | 2000-09-21 | 2006-07-18 | Amgen Inc. | Selective binding agents of telomerase |
US6713055B2 (en) | 2000-11-27 | 2004-03-30 | Geron Corporation | Glycosyltransferase vectors for treating cancer |
US6576464B2 (en) | 2000-11-27 | 2003-06-10 | Geron Corporation | Methods for providing differentiated stem cells |
AU2002226076A1 (en) * | 2000-12-14 | 2002-06-24 | The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services | Telomerase immortalized human liver cell lines |
US6906237B2 (en) * | 2001-02-27 | 2005-06-14 | G. Scott Herron | Vivo assay for anti angiogenic compounds |
US20040063922A1 (en) * | 2001-04-17 | 2004-04-01 | Conrad Charles A. | Methods and compositions for catalytic DNA exchange in a sequence specific manner |
US7262174B2 (en) * | 2001-05-09 | 2007-08-28 | Geron Corporation | Treatment for wounds |
GB0112342D0 (en) * | 2001-05-21 | 2001-07-11 | Norsk Hydro As | Polypeptides |
EP1408109B1 (fr) | 2001-07-16 | 2008-07-09 | Fuyuki Ishikawa | Nouvelle méthode pour induire la sénescence cellulaire et méthode de criblage d'agent anti-âge |
WO2003014320A2 (fr) * | 2001-08-10 | 2003-02-20 | Cornell Research Foundation, Inc. | Cellules souches neuronales humaines immortalisees issues de la telomerase et cellules souches a restriction phenotypique |
AUPR769701A0 (en) * | 2001-09-14 | 2001-10-11 | Li, He | Telomerase inhibitory peptides and uses thereof |
DE50214367D1 (de) * | 2001-10-18 | 2010-05-27 | Heart Biosystems Gmbh | Transiente immortalisierung von zellen durch onkogenproteine oder telomerproteine |
CA2478681A1 (fr) * | 2001-10-22 | 2003-05-01 | University Of Rochester | Interference par telomerase |
JPWO2003038076A1 (ja) * | 2001-10-31 | 2005-02-24 | 株式会社レノメディクス研究所 | 不死化間葉系細胞及びその利用 |
JP5364224B2 (ja) | 2001-12-07 | 2013-12-11 | ジェロン・コーポレーション | ヒト胚性幹細胞に由来する造血細胞 |
CA2692325C (fr) | 2001-12-07 | 2015-10-20 | Geron Corporation | Cellules d'ilots pancreatiques provenant de cellules souches embryonnaires humaines |
DE10163130B4 (de) * | 2001-12-20 | 2009-05-14 | Cyto Tools Gmbh | Apoptotisch wirksame Peptide und diese umfassende pharmazeutische Zusammensetzungen |
AU2002357613A1 (en) * | 2001-12-21 | 2003-07-09 | Shuichi Kaneko | Method of detecting antitelomerase antibody |
GB0200929D0 (en) * | 2002-01-16 | 2002-03-06 | Univ Glasgow | Tissue rejection |
EP1474522B1 (fr) * | 2002-01-18 | 2012-03-07 | Morphotek, Inc. | Methode de generation de cellules genetiquement modifiees pour la regulation et l'analyse de genes specifiques d'un locus |
US20030175961A1 (en) * | 2002-02-26 | 2003-09-18 | Herron G. Scott | Immortal micorvascular endothelial cells and uses thereof |
US20050106729A1 (en) * | 2002-05-03 | 2005-05-19 | Mark Irvin Rosenblatt | Gene transfer methods and compositions |
WO2003100025A2 (fr) * | 2002-05-28 | 2003-12-04 | Regents Of The University Of Minnesota | Utilisation de polyppetides crisp comme contaceptifs et inhibiteurs de capacitation du sperme |
US7294708B2 (en) * | 2002-05-31 | 2007-11-13 | Beijing Institute Of Biotechnology | Telomerase reverse transcriptase fragments and uses thereof |
US7262025B2 (en) * | 2002-06-18 | 2007-08-28 | Zymogenetics, Inc. | Hybrid vector having a cytomegalovirus enhancer and myeloproliferative sarcoma virus promoter |
US7285415B2 (en) | 2002-07-11 | 2007-10-23 | The Regents Of The University Of California | Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury |
JP2006505291A (ja) | 2002-11-08 | 2006-02-16 | ヘマテック,エルエルシー | プリオンタンパク質活性が低減されたトランスジェニック有蹄動物及びその用途 |
US7166692B2 (en) * | 2003-03-04 | 2007-01-23 | Canbrex Bio Science Walkersville, Inc. | Intracellular delivery of small molecules, proteins, and nucleic acids |
WO2004099385A2 (fr) * | 2003-04-30 | 2004-11-18 | Duke University | Allongement de telomere |
DK1644009T3 (en) | 2003-06-23 | 2018-03-05 | Telomerase Activation Sciences Inc | Compositions for increasing telomerase activity and treating HIV infection |
AU2004272340B2 (en) * | 2003-09-12 | 2008-01-03 | Dana Farber Cancer Institute | Immortalisation of mammalian cells and therapeutic applications of said cells |
EP1522858A1 (fr) * | 2003-10-10 | 2005-04-13 | Jean-Christophe Roegel | Procédé de sélection de composés utilisant des anticorps agissant comme agoniste, antagoniste ou modulateur allostériques |
US7473418B2 (en) | 2004-03-25 | 2009-01-06 | Cell Genesys, Inc. | Pan cancer oncolytic vectors and methods of use thereof |
JP2007533328A (ja) | 2004-04-22 | 2007-11-22 | キリンホールディングス株式会社 | トランスジェニック動物及びその用途 |
CA2565858C (fr) | 2004-05-11 | 2021-06-22 | Axiogenesis Ag | Dosage pour la decouverte de medicament reposant sur des cellules differenciees in vitro |
WO2006031313A2 (fr) * | 2004-08-05 | 2006-03-23 | The Board Of Trustees Of The Leland Stanford Junior University | Procedes et compositions pour l'activation de cellules |
US8697139B2 (en) | 2004-09-21 | 2014-04-15 | Frank M. Phillips | Method of intervertebral disc treatment using articular chondrocyte cells |
JP2006242618A (ja) * | 2005-03-01 | 2006-09-14 | Univ Of Tokyo | 組織fish法によるテロメア量を指標とした癌の診断 |
JP4635196B2 (ja) * | 2005-03-04 | 2011-02-16 | 国立大学法人広島大学 | 遺伝子導入細胞、及びそれを用いたテロメラーゼ誘導物質の検出方法 |
EP1871887A2 (fr) * | 2005-03-09 | 2008-01-02 | Board of Regents, The University of Texas System | Promoteur htmc et vecteurs destines a l'expression hautement efficace et selective pour une tumeur de genes therapeutiques contre le cancer |
US20090305236A1 (en) * | 2005-05-11 | 2009-12-10 | Genetic Technologies Limited | Methods of enriching fetal cells |
EP1748067A1 (fr) * | 2005-07-29 | 2007-01-31 | Institut Pasteur | Polynucleotides codant pour des épitopes de la hTERT restreints au CMH de classe I, analogues et polyépitopes |
DE602006020071D1 (de) | 2005-12-21 | 2011-03-24 | Univ Catholique Louvain | Isolierte leberstammzellen |
WO2007149182A2 (fr) | 2006-06-19 | 2007-12-27 | Geron Corporation | Différenciation et enrichissement de cellules de type cellules des îlots pancréatiques à partir de cellules souches pluripotentes humaines |
US20080131442A1 (en) * | 2006-06-26 | 2008-06-05 | Science Applications International Corporation | IgY antibodies to human telomerase reverse transcriptase |
WO2008002285A1 (fr) * | 2006-06-26 | 2008-01-03 | Science Applications International Corporation | Anticorps igy contre la transcriptase inverse de la télomérase humaine |
CN105063064A (zh) * | 2006-07-28 | 2015-11-18 | 宾夕法尼亚大学托管会 | 改进的疫苗及其使用方法 |
AU2013203229C1 (en) * | 2006-07-28 | 2015-10-29 | The Trustees Of The University Of Pennsylvania | Improved vaccines and methods for using the same |
ES2376010T3 (es) * | 2006-10-12 | 2012-03-08 | Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.R.L. | Prote�?na de fusión de transcriptasa inversa de la telomerasa, nucleótidos que la codifican y usos de la misma. |
EP2088864B1 (fr) | 2006-11-03 | 2017-08-16 | The Board of Trustees of the Leland Stanford Junior University | Immunodéplétion sélective de niche de cellules souches endogènes pour greffe |
EP1994942A1 (fr) * | 2007-05-25 | 2008-11-26 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Compositions pharmaceutiques comprenant de la télomérase et leurs utilisations |
WO2009091811A1 (fr) | 2008-01-14 | 2009-07-23 | Brenzel Michael P | Appareil et procédés de réparation des fractures |
US9782565B2 (en) | 2008-10-01 | 2017-10-10 | Covidien Lp | Endoscopic ultrasound-guided biliary access system |
US9332973B2 (en) | 2008-10-01 | 2016-05-10 | Covidien Lp | Needle biopsy device with exchangeable needle and integrated needle protection |
US11298113B2 (en) | 2008-10-01 | 2022-04-12 | Covidien Lp | Device for needle biopsy with integrated needle protection |
US8968210B2 (en) | 2008-10-01 | 2015-03-03 | Covidien LLP | Device for needle biopsy with integrated needle protection |
US9186128B2 (en) | 2008-10-01 | 2015-11-17 | Covidien Lp | Needle biopsy device |
US9447467B2 (en) | 2009-04-21 | 2016-09-20 | Genetic Technologies Limited | Methods for obtaining fetal genetic material |
EP2451941B1 (fr) * | 2009-07-09 | 2018-06-13 | Janssen Biotech, Inc. | Cellules dérivées de tissus cardiaques |
WO2011088172A1 (fr) | 2010-01-15 | 2011-07-21 | Brenzel Michael P | Tige orthopédique tournante rigide |
AU2011207550B2 (en) | 2010-01-20 | 2016-03-10 | Conventus Orthopaedics, Inc. | Apparatus and methods for bone access and cavity preparation |
KR20130024888A (ko) | 2010-02-16 | 2013-03-08 | 오슬로 유니버시티 하스피탈 에이치에프 | 폴리펩티드 |
US9249452B2 (en) * | 2010-02-26 | 2016-02-02 | Zhu Zhen Pirot | Method of detecting and assaying telomerase activity of telomerase bound by anti-telomerase antibodies |
CA2829193A1 (fr) | 2010-03-08 | 2011-09-15 | Conventus Orthopaedics, Inc. | Appareil et procedes de fixation d'implant osseux |
SG184440A1 (en) | 2010-04-08 | 2012-11-29 | Univ Edinburgh | Chondrogenic progenitor cells, protocol for derivation of cells and uses thereof |
WO2012026309A1 (fr) * | 2010-08-23 | 2012-03-01 | 公立大学法人横浜市立大学 | Création d'un médicament anticorps anti-pad4 |
CN102093980B (zh) * | 2010-12-10 | 2013-04-17 | 梁伟国 | 永生化人椎间盘髓核细胞体系的制备方法 |
US8420617B2 (en) * | 2011-03-11 | 2013-04-16 | Biocell Laboratories | Multiantivirus compound, composition and method for treatment of virus diseases |
CN102676518B (zh) * | 2012-02-27 | 2013-09-18 | 华侨大学 | 一种新型抗肿瘤amiRNA序列及其应用 |
EP2639299A1 (fr) | 2012-03-16 | 2013-09-18 | Invectys | Peptides universels du cancer dérivés de la télomérase |
US9907837B2 (en) * | 2012-05-11 | 2018-03-06 | Gemvax & Kael Co., Ltd. | Composition for preventing or treating cachexia |
CN115927242A (zh) * | 2012-05-11 | 2023-04-07 | 珍白斯凯尔有限公司 | 具有抗炎活性的肽及其在制备抗炎组合物中的应用 |
CN108624654A (zh) * | 2012-06-27 | 2018-10-09 | 新泽西鲁特格斯州立大学 | 通过使用流式细胞术的rna测量快速检测t细胞活化 |
US20150125438A1 (en) * | 2012-07-20 | 2015-05-07 | Sang Jae Kim | Anti-Inflammatory Peptides and Composition Comprising the Same |
CN104837859B (zh) * | 2012-09-19 | 2019-02-22 | 珍白斯凯尔有限公司 | 细胞穿透肽、包含该肽的缀合物、及包含该缀合物的组合物 |
KR102038487B1 (ko) | 2012-09-19 | 2019-10-30 | 주식회사 젬백스앤카엘 | 텔로머라제 펩티드를 포함하는 항균 또는 항진균용 조성물 |
CN110028554B (zh) * | 2012-09-19 | 2023-04-07 | 珍白斯凯尔有限公司 | 细胞穿透性肽、包含该肽的缀合物、及包含该缀合物的组合物 |
KR102166542B1 (ko) | 2012-09-28 | 2020-10-16 | 주식회사 젬백스앤카엘 | 줄기세포 검출을 위한 텔로머라제 유래 펩티드 및 조영물질의 컨쥬게이트 및 이를 포함하는 조영제 |
KR102093093B1 (ko) | 2012-12-13 | 2020-03-25 | 주식회사 젬백스앤카엘 | 피부 노화 개선용 조성물 |
KR102106756B1 (ko) | 2012-12-13 | 2020-05-06 | 주식회사 젬백스앤카엘 | 자외선에 의한 피부 손상 예방 또는 치료용 조성물 |
CA2902237C (fr) | 2013-02-22 | 2024-02-13 | The Board Of Trustees Of The Leland Stanford Junior University | Composes, compositions, procedes, et kits lies a l'extension de telomeres |
AU2014242915B2 (en) | 2013-03-28 | 2018-08-09 | Invectys | A cancer vaccine for cats |
JP6479761B2 (ja) | 2013-03-28 | 2019-03-06 | アンヴェクティInvectys | イヌ用がんワクチン |
CN106414718A (zh) | 2013-06-11 | 2017-02-15 | 哈佛学院校长同事会 | SC-β细胞以及用于产生其的组合物和方法 |
ES2753412T3 (es) | 2013-10-28 | 2020-04-08 | Invectys | Electrotransferencia génica a las células de la piel |
EP3062824B1 (fr) | 2013-10-28 | 2019-11-27 | Invectys | Vaccin d'adn de codage de la télomérase |
EP2871235A1 (fr) * | 2013-11-07 | 2015-05-13 | Centre National de la Recherche Scientifique (CNRS) | Nouveaux procédés pour produire un hTERT actif |
WO2015089357A2 (fr) | 2013-12-12 | 2015-06-18 | Conventus Orthopaedics, Inc. | Outils et méthodes de déplacement de tissu |
KR102166549B1 (ko) | 2014-01-10 | 2020-10-16 | 주식회사 젬백스앤카엘 | 혈뇌장벽 투과성 펩티드 및 이를 포함하는 컨쥬게이트 |
CA3229961A1 (fr) | 2014-08-26 | 2016-03-03 | The Board Of Trustees Of The Leland Stanford Junior University | Greffe de cellules souches avec combinaison d'un agent ciblant des cellules souches et modulation de la signalisation immunoregulatrice |
WO2017079419A1 (fr) | 2015-11-05 | 2017-05-11 | The Regents Of The University Of California | Cellules marquées par des conjugués lipidiques et méthodes d'utilisation de ces dernières |
ES2811523T3 (es) | 2016-01-19 | 2021-03-12 | Pfizer | Vacunas contra el cáncer |
US20180214524A1 (en) | 2017-01-30 | 2018-08-02 | The Board Of Trustees Of The Leland Stanford Junior University | Non-genotoxic conditioning regimen for stem cell transplantation |
US10631881B2 (en) | 2017-03-09 | 2020-04-28 | Flower Orthopedics Corporation | Plating depth gauge and countersink instrument |
EP3622078A1 (fr) | 2017-05-09 | 2020-03-18 | Invectys | Vaccin contre la rougeole recombinant exprimant htert |
WO2019010252A2 (fr) | 2017-07-04 | 2019-01-10 | Conventus Orthopaedics, Inc. | Appareil et méthodes de traitement d'os |
US11786557B2 (en) | 2017-10-02 | 2023-10-17 | Fred Hutchinson Cancer Center | Luteinizing hormone receptor binding agents and luteinizing hormone agonists to identify, expand, ablate and modify stem cells |
CN108715863B (zh) * | 2018-05-30 | 2020-09-11 | 吉林大学 | 一种肿瘤靶向性载体pcTERT及其构建方法及其应用 |
CN110827920B (zh) * | 2018-08-14 | 2022-11-22 | 武汉华大医学检验所有限公司 | 测序数据分析方法和设备及高通量测序方法 |
CN112930404A (zh) * | 2018-09-05 | 2021-06-08 | 瑞德库尔有限责任公司 | 用于治疗剂分析的方法和系统 |
US20210238564A1 (en) * | 2018-09-06 | 2021-08-05 | The Board Of Regents Of The University Of Texas System | Telomerase holoenzyme complex and methods of use thereof |
CN109545039A (zh) * | 2019-01-15 | 2019-03-29 | 苏州大学 | 一种核孔复合体结构模型教具及其使用方法 |
WO2021007180A1 (fr) | 2019-07-05 | 2021-01-14 | Case Western Reserve University | Milieu d'amorçage et procédés pour la culture et la thérapie de cellules souches |
JP2021151979A (ja) * | 2020-03-24 | 2021-09-30 | 均 石井 | 再生医療薬 |
CN112063601B (zh) * | 2020-09-22 | 2023-06-02 | 浙江愈方生物科技有限公司 | 一种灭活性端粒酶、具有其的腺病毒和人造mRNA及应用 |
JP2022151412A (ja) * | 2021-03-23 | 2022-10-07 | 均 石井 | 脳卒中治療薬 |
CN113355303B (zh) * | 2021-06-07 | 2023-06-16 | 中元汇吉生物技术股份有限公司 | 一种m-mlv逆转录酶突变体及其应用 |
WO2023141534A1 (fr) * | 2022-01-19 | 2023-07-27 | Northwestern University | Agents ciblant la transcriptase inverse de la télomérase (tert) pour traiter le cancer et sensibiliser des cellules cancéreuses à une thérapie génotoxique |
CN114920802B (zh) * | 2022-05-16 | 2023-05-23 | 中国地质大学(武汉) | 调节端粒酶限速蛋白运动的多肽探针及其复合物和方法 |
CN116364195B (zh) * | 2023-05-10 | 2023-10-13 | 浙大城市学院 | 一种基于预训练模型的微生物遗传序列表型预测方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996001835A1 (fr) * | 1994-07-07 | 1996-01-25 | Geron Corporation | Telomerase mammifere |
Family Cites Families (148)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US912629A (en) | 1908-08-29 | 1909-02-16 | Conrad L Stueber | Foundation-top for pipe-carriers. |
NL154598B (nl) | 1970-11-10 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking. |
US3817837A (en) | 1971-05-14 | 1974-06-18 | Syva Corp | Enzyme amplification assay |
US3939350A (en) | 1974-04-29 | 1976-02-17 | Board Of Trustees Of The Leland Stanford Junior University | Fluorescent immunoassay employing total reflection for activation |
US3996345A (en) | 1974-08-12 | 1976-12-07 | Syva Company | Fluorescence quenching with immunological pairs in immunoassays |
US4277437A (en) | 1978-04-05 | 1981-07-07 | Syva Company | Kit for carrying out chemically induced fluorescence immunoassay |
US4275149A (en) | 1978-11-24 | 1981-06-23 | Syva Company | Macromolecular environment control in specific receptor assays |
US4254082A (en) | 1978-06-12 | 1981-03-03 | Miles Laboratories, Inc. | Specific binding-adsorbent assay test means |
US4657760A (en) | 1979-03-20 | 1987-04-14 | Ortho Pharmaceutical Corporation | Methods and compositions using monoclonal antibody to human T cells |
US4458066A (en) | 1980-02-29 | 1984-07-03 | University Patents, Inc. | Process for preparing polynucleotides |
WO1982001461A1 (fr) | 1980-07-18 | 1982-05-13 | Leland Stanford Junior Univ | Hybridomes humains, precurseurs et produits |
US4376110A (en) | 1980-08-04 | 1983-03-08 | Hybritech, Incorporated | Immunometric assays using monoclonal antibodies |
US4366241A (en) | 1980-08-07 | 1982-12-28 | Syva Company | Concentrating zone method in heterogeneous immunoassays |
US4554101A (en) * | 1981-01-09 | 1985-11-19 | New York Blood Center, Inc. | Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity |
US4517288A (en) | 1981-01-23 | 1985-05-14 | American Hospital Supply Corp. | Solid phase system for ligand assay |
US5055556A (en) | 1981-10-06 | 1991-10-08 | The Board Of Trustees Of The Leland Stanford Jr. Univ. | Fluorescent conjugates for analysis of molecules and cells |
JPS58215453A (ja) | 1982-06-09 | 1983-12-14 | Toray Silicone Co Ltd | 室温硬化後塗装可能なオルガノポリシロキサン組成物 |
FR2542494B1 (fr) | 1983-03-08 | 1985-08-16 | Sevylor International | Combinaison protectrice, utilisable notamment en atmosphere irradiee |
NZ207394A (en) | 1983-03-08 | 1987-03-06 | Commw Serum Lab Commission | Detecting or determining sequence of amino acids |
US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
US5272065A (en) | 1983-10-20 | 1993-12-21 | Research Foundation Of State University Of New York | Regulation of gene expression by employing translational inhibition of MRNA utilizing interfering complementary MRNA |
US5049386A (en) | 1985-01-07 | 1991-09-17 | Syntex (U.S.A.) Inc. | N-ω,(ω-1)-dialkyloxy)- and N-(ω,(ω-1)-dialkenyloxy)Alk-1-YL-N,N,N-tetrasubstituted ammonium lipids and uses therefor |
US4897355A (en) | 1985-01-07 | 1990-01-30 | Syntex (U.S.A.) Inc. | N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor |
US4946787A (en) | 1985-01-07 | 1990-08-07 | Syntex (U.S.A.) Inc. | N-(ω,(ω-1)-dialkyloxy)- and N-(ω,(ω-1)-dialkenyloxy)-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor |
US5034506A (en) | 1985-03-15 | 1991-07-23 | Anti-Gene Development Group | Uncharged morpholino-based polymers having achiral intersubunit linkages |
US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
US4965188A (en) | 1986-08-22 | 1990-10-23 | Cetus Corporation | Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme |
US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
US5206344A (en) | 1985-06-26 | 1993-04-27 | Cetus Oncology Corporation | Interleukin-2 muteins and polymer conjugation thereof |
CA1291031C (fr) | 1985-12-23 | 1991-10-22 | Nikolaas C.J. De Jaeger | Methode pour la detection de liants specifiques et des substances liables par ceux-ci |
GB8612087D0 (en) | 1986-05-19 | 1986-06-25 | Ici Plc | Hybridisation probes |
US5001225A (en) | 1986-12-08 | 1991-03-19 | Georgetown University | Monoclonal antibodies to a pan-malarial antigen |
US4889806A (en) | 1987-04-15 | 1989-12-26 | Washington University | Large DNA cloning system based on yeast artificial chromosomes |
US5017478A (en) | 1987-07-16 | 1991-05-21 | Berlex Laboratories, Inc. | Transfected cells containing plasmids having genes oriented in opposing directions and methods of using |
US5124246A (en) | 1987-10-15 | 1992-06-23 | Chiron Corporation | Nucleic acid multimers and amplified nucleic acid hybridization assays using same |
US5093245A (en) | 1988-01-26 | 1992-03-03 | Applied Biosystems | Labeling by simultaneous ligation and restriction |
US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
US5075227A (en) * | 1989-03-07 | 1991-12-24 | Zymogenetics, Inc. | Directional cloning |
JPH02307059A (ja) | 1989-05-23 | 1990-12-20 | Seiko Instr Inc | 反応容器 |
US5143854A (en) | 1989-06-07 | 1992-09-01 | Affymax Technologies N.V. | Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof |
US5437994A (en) | 1989-06-15 | 1995-08-01 | Regents Of The University Of Michigan | Method for the ex vivo replication of stem cells, for the optimization of hematopoietic progenitor cell cultures, and for increasing the metabolism, GM-CSF secretion and/or IL-6 secretion of human stromal cells |
US5399493A (en) | 1989-06-15 | 1995-03-21 | The Regents Of The University Of Michigan | Methods and compositions for the optimization of human hematopoietic progenitor cell cultures |
US5464764A (en) | 1989-08-22 | 1995-11-07 | University Of Utah Research Foundation | Positive-negative selection methods and vectors |
US5545522A (en) | 1989-09-22 | 1996-08-13 | Van Gelder; Russell N. | Process for amplifying a target polynucleotide sequence using a single primer-promoter complex |
US5225212A (en) | 1989-10-20 | 1993-07-06 | Liposome Technology, Inc. | Microreservoir liposome composition and method |
ES2090299T3 (es) | 1989-12-01 | 1996-10-16 | Pharming Bv | Produccion de polipeptidos recombinantes mediante especies bovinas y metodos transgenicos. |
AU647741B2 (en) | 1989-12-01 | 1994-03-31 | Regents Of The University Of California, The | Methods and compositions for chromosome-specific staining |
EP0779362B2 (fr) | 1989-12-22 | 2012-06-13 | Laboratoires Serono SA | Constructions de type ADN pour l'activation et la modification de l'expression de gènes endogènes |
US5272071A (en) | 1989-12-22 | 1993-12-21 | Applied Research Systems Ars Holding N.V. | Method for the modification of the expression characteristics of an endogenous gene of a given cell line |
JPH04505546A (ja) | 1990-02-09 | 1992-09-24 | アスラブ ソシエテ アノニム | 写真平版マイクロ製造法を用いて製造した放射場静電マイクロモーター及び前記マイクロモーターの製造方法 |
US5264618A (en) | 1990-04-19 | 1993-11-23 | Vical, Inc. | Cationic lipids for intracellular delivery of biologically active molecules |
US5427908A (en) | 1990-05-01 | 1995-06-27 | Affymax Technologies N.V. | Recombinant library screening methods |
WO1991017424A1 (fr) | 1990-05-03 | 1991-11-14 | Vical, Inc. | Acheminement intracellulaire de substances biologiquement actives effectue a l'aide de complexes de lipides s'auto-assemblant |
SE468913B (sv) | 1990-05-16 | 1993-04-05 | Igesto Ab | Saekerhetskrok |
GB9015198D0 (en) | 1990-07-10 | 1990-08-29 | Brien Caroline J O | Binding substance |
US5545806A (en) | 1990-08-29 | 1996-08-13 | Genpharm International, Inc. | Ransgenic non-human animals for producing heterologous antibodies |
WO1992003918A1 (fr) | 1990-08-29 | 1992-03-19 | Genpharm International, Inc. | Animaux non humains transgeniques capables de produire des anticorps heterologues |
IL99552A0 (en) | 1990-09-28 | 1992-08-18 | Ixsys Inc | Compositions containing procaryotic cells,a kit for the preparation of vectors useful for the coexpression of two or more dna sequences and methods for the use thereof |
KR100198659B1 (ko) | 1996-05-16 | 1999-06-15 | 구본준 | 메모리 셀, 메모리 장치 및 그의 제조 방법 |
EP0566714B1 (fr) | 1991-10-11 | 1997-01-02 | Promega Corporation | Transcription et traduction couplees dans un extrait acellulaire eucaryotique |
US6270989B1 (en) | 1991-11-05 | 2001-08-07 | Transkaryotic Therapies, Inc. | Protein production and delivery |
NZ245015A (en) | 1991-11-05 | 1995-12-21 | Transkaryotic Therapies Inc | Delivery of human growth hormone through the administration of transfected cell lines encoding human growth hormone, which are physically protected from host immune response; the transfected cells and their production |
US5641670A (en) | 1991-11-05 | 1997-06-24 | Transkaryotic Therapies, Inc. | Protein production and protein delivery |
CA2135646A1 (fr) | 1992-05-11 | 1993-11-25 | Kenneth G. Draper | Methode et reagent permettant l'inhibition de la replication virale |
US5645986A (en) | 1992-05-13 | 1997-07-08 | Board Of Reagents, The University Of Texas System | Therapy and diagnosis of conditions related to telomere length and/or telomerase activity |
US5489508A (en) | 1992-05-13 | 1996-02-06 | University Of Texas System Board Of Regents | Therapy and diagnosis of conditions related to telomere length and/or telomerase activity |
US5629154A (en) | 1993-11-12 | 1997-05-13 | Geron Corporation | Telomerase activity assays |
US5639613A (en) | 1992-05-13 | 1997-06-17 | Board Of Regents, University Of Texas System | Methods for cancer diagnosis and prognosis |
US5648215A (en) | 1992-05-13 | 1997-07-15 | Board Of Regents, The University Of Texas System | Telomerase diagnostic methods |
EP0786522A2 (fr) | 1992-07-17 | 1997-07-30 | Ribozyme Pharmaceuticals, Inc. | Molécules de RNA enzymatiques pour le traitement de conditions sténotiques |
US6107062A (en) | 1992-07-30 | 2000-08-22 | Inpax, Inc. | Antisense viruses and antisense-ribozyme viruses |
GB2273932A (en) | 1992-11-24 | 1994-07-06 | Stiefel Laboratories | Stable oligonucleotides |
US5674703A (en) | 1992-12-02 | 1997-10-07 | Woo; Savio L. C. | Episomal vector systems and related methods |
AU680459B2 (en) | 1992-12-03 | 1997-07-31 | Genzyme Corporation | Gene therapy for cystic fibrosis |
TW402639B (en) | 1992-12-03 | 2000-08-21 | Transkaryotic Therapies Inc | Protein production and protein delivery |
EP0686200A4 (fr) | 1993-01-27 | 1997-07-02 | Oncor Inc | Amplification de sequences d'acides nucleiques |
US6120764A (en) | 1993-06-24 | 2000-09-19 | Advec, Inc. | Adenoviruses for control of gene expression |
US5919676A (en) | 1993-06-24 | 1999-07-06 | Advec, Inc. | Adenoviral vector system comprising Cre-loxP recombination |
US6140087A (en) | 1993-06-24 | 2000-10-31 | Advec, Inc. | Adenovirus vectors for gene therapy |
WO1995013382A1 (fr) * | 1993-11-12 | 1995-05-18 | Geron Corporation | Diagnostic et traitement de desordres lies a la longueur de telomeres et/ou l'activite de la telomerase |
US5578832A (en) | 1994-09-02 | 1996-11-26 | Affymetrix, Inc. | Method and apparatus for imaging a sample on a device |
US5583016A (en) | 1994-07-07 | 1996-12-10 | Geron Corporation | Mammalian telomerase |
US5597697A (en) | 1994-09-30 | 1997-01-28 | Diamond; Paul | Screening assay for inhibitors and activators of RNA and DNA-dependent nucleic acid polymerases |
US5698686A (en) * | 1994-10-20 | 1997-12-16 | Arch Development Corporation | Yeast telomerase compositions |
US5556752A (en) | 1994-10-24 | 1996-09-17 | Affymetrix, Inc. | Surface-bound, unimolecular, double-stranded DNA |
WO1996019580A2 (fr) * | 1994-12-19 | 1996-06-27 | Cold Spring Harbor Laboratory | Fraction proteinique de la telomerase |
US5722998A (en) | 1995-06-07 | 1998-03-03 | Intermedics, Inc. | Apparatus and method for the control of an implantable medical device |
US5741677A (en) | 1995-06-07 | 1998-04-21 | Geron Corporation | Methods for measuring telomere length |
WO1997015687A1 (fr) | 1995-06-07 | 1997-05-01 | Geron Corporation | Dosage de l'activite de la telomerase |
EP0832190A1 (fr) | 1995-06-07 | 1998-04-01 | Cold Spring Harbor Laboratory | Oligonucleotides essentiels de la telomerase de vertebre |
EP0784542B1 (fr) | 1995-08-04 | 2001-11-28 | International Business Machines Corporation | Tampon lithographique |
US6517834B1 (en) | 1995-08-04 | 2003-02-11 | Geron Corporation | Purified telomerase |
US6545133B1 (en) | 1995-08-04 | 2003-04-08 | Geron Corporation | Methods for purifying telomerase |
US5968506A (en) | 1995-08-04 | 1999-10-19 | Geron Corporation | Purified telomerase |
JPH09154575A (ja) | 1995-10-04 | 1997-06-17 | Soosei:Kk | テロメラーゼ |
JPH09164575A (ja) | 1995-12-13 | 1997-06-24 | Japan Steel Works Ltd:The | 流れ模様を有する樹脂板の製造方法およびその装置 |
US6015710A (en) | 1996-04-09 | 2000-01-18 | The University Of Texas System | Modulation of mammalian telomerase by peptide nucleic acids |
US5853719A (en) | 1996-04-30 | 1998-12-29 | Duke University | Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA |
US5770422A (en) | 1996-07-08 | 1998-06-23 | The Regents Of The University Of California | Human telomerase |
US5747317A (en) | 1996-07-08 | 1998-05-05 | Tularik Inc. | Human telomerase RNA interacting protein gene |
US5724021A (en) | 1996-07-09 | 1998-03-03 | Stephen C. Perrone | Self-contained, programmable, time interval alarm reminder device for eyedrop medication administration and a means for affixing such to eyedrop/medication container |
WO1998007838A1 (fr) | 1996-08-21 | 1998-02-26 | Mitsubishi Chemical Corporation | Proteine de telomerase d'animaux superieurs et gene codant pour elle |
WO1998008938A1 (fr) | 1996-08-28 | 1998-03-05 | Shonen Yoshida | Proteines ayant une activite de telomerase |
DE19638482A1 (de) | 1996-09-20 | 1998-04-02 | Bosch Gmbh Robert | Verfahren zur Auswahl einer Sendefrequenz |
US6808880B2 (en) | 1996-10-01 | 2004-10-26 | Geron Corporation | Method for detecting polynucleotides encoding telomerase |
US6610839B1 (en) | 1997-08-14 | 2003-08-26 | Geron Corporation | Promoter for telomerase reverse transcriptase |
US7585622B1 (en) | 1996-10-01 | 2009-09-08 | Geron Corporation | Increasing the proliferative capacity of cells using telomerase reverse transcriptase |
ATE245194T1 (de) | 1996-10-01 | 2003-08-15 | Geron Corp | Katalytische untereinheit der menschlichen telomerase |
US6444650B1 (en) | 1996-10-01 | 2002-09-03 | Geron Corporation | Antisense compositions for detecting and inhibiting telomerase reverse transcriptase |
US6777203B1 (en) | 1997-11-19 | 2004-08-17 | Geron Corporation | Telomerase promoter driving expression of therapeutic gene sequences |
US6261836B1 (en) | 1996-10-01 | 2001-07-17 | Geron Corporation | Telomerase |
US6093809A (en) | 1996-10-01 | 2000-07-25 | University Technology Corporation | Telomerase |
US6475789B1 (en) | 1996-10-01 | 2002-11-05 | University Technology Corporation | Human telomerase catalytic subunit: diagnostic and therapeutic methods |
US6767719B1 (en) | 1997-11-26 | 2004-07-27 | Geron Corporation | Mouse telomerase reverse transcriptase |
US5890326A (en) | 1996-11-06 | 1999-04-06 | Hill-Rom, Inc. | Head wall for a hospital room |
US5919656A (en) | 1996-11-15 | 1999-07-06 | Amgen Canada Inc. | Genes encoding telomerase protein 1 |
US7390891B1 (en) | 1996-11-15 | 2008-06-24 | Amgen Inc. | Polynucleotides encoding a telomerase component TP2 |
EP0942991A2 (fr) | 1996-11-26 | 1999-09-22 | Baylor College Of Medicine | Identification d'inhibiteurs empechant l'acces de la telomerase aux terminaisons chromosomiques |
WO1998037181A2 (fr) * | 1997-02-20 | 1998-08-27 | Whitehead Institute For Biomedical Research | Gene de sous-unite catalytique de telomerase et proteine codee |
US6617119B2 (en) | 1997-02-21 | 2003-09-09 | The Regents Of The University Of California | Assay for specific strains of multiple disease related conformations of a protein |
ES2208895T3 (es) * | 1997-04-04 | 2004-06-16 | Geron Corporation | Telomerasa purificada. |
US6485789B1 (en) | 1997-04-14 | 2002-11-26 | 3M Innovative Properties Company | Fluorochemical composition containing a condensation product of a fluorochemical polyether and a poly-isocyanate to impart stain release properties to a substrate |
US20050013825A1 (en) | 1997-04-18 | 2005-01-20 | Geron Corporation | Vaccine containing the catalytic subunit of telomerase for treating cancer |
US7413864B2 (en) | 1997-04-18 | 2008-08-19 | Geron Corporation | Treating cancer using a telomerase vaccine |
US7622549B2 (en) | 1997-04-18 | 2009-11-24 | Geron Corporation | Human telomerase reverse transcriptase polypeptides |
US6201830B1 (en) | 1997-06-11 | 2001-03-13 | Texas Instruments Incorporated | Low computation idle transmission method for DSL modems |
AU745420B2 (en) * | 1997-06-20 | 2002-03-21 | Bayer Aktiengesellschaft | Human catalytic telomerase sub-unit and its diagnostic and therapeutic use |
IL133830A0 (en) | 1997-07-01 | 2001-04-30 | Cambia Biosystems Llc | Vertebrate tolomerase genes and proteins and uses thereof |
US7378244B2 (en) | 1997-10-01 | 2008-05-27 | Geron Corporation | Telomerase promoters sequences for screening telomerase modulators |
WO2000046355A2 (fr) | 1999-02-04 | 2000-08-10 | Geron Corporation | Sequences de regulation transcriptionnelle de la transcriptase inverse de la telomerase |
AU1606999A (en) | 1997-11-26 | 1999-06-15 | Albert Einstein College Of Medicine Of Yeshiva University | Mouse telomerase reverse transcriptase |
DE19757984A1 (de) | 1997-12-24 | 1999-07-01 | Bayer Ag | Regulatorische DNA-Sequenzen aus der 5'-Region vom Gen der humanen katalytischen Telomerase-Untereinheit udn deren diagnostische und therapeutische Verwendung |
ATE328079T1 (de) | 1998-01-08 | 2006-06-15 | Chugai Pharmaceutical Co Ltd | Neues gen mit einem revers-transkriptase-motiv |
GB9801902D0 (en) | 1998-01-29 | 1998-03-25 | Cancer Res Campaign Tech | A gene promoter |
US6337200B1 (en) | 1998-03-31 | 2002-01-08 | Geron Corporation | Human telomerase catalytic subunit variants |
US7402307B2 (en) | 1998-03-31 | 2008-07-22 | Geron Corporation | Method for identifying and killing cancer cells |
JP2002509716A (ja) | 1998-03-31 | 2002-04-02 | ユニバーシティ テクノロジー コーポレイション | テロメラーゼ抗原に対する免疫応答を惹起するための方法および組成物 |
EP1085892A4 (fr) | 1998-06-12 | 2002-07-17 | Sloan Kettering Inst Cancer | Strategie de vaccination permettant de prevenir et de traiter les cancers |
US7030211B1 (en) * | 1998-07-08 | 2006-04-18 | Gemvax As | Antigenic peptides derived from telomerase |
EP1171612A2 (fr) | 1999-04-09 | 2002-01-16 | Biomira, Inc. | Vaccin anticancereux specifique de la telomerase |
WO2000073420A2 (fr) | 1999-06-02 | 2000-12-07 | Whitehead Institute For Biomedical Research | Creation de cellules tumorigenes humaines et utilisations correspondante |
US6354941B2 (en) | 1999-11-03 | 2002-03-12 | 516 Holdings | Electronic system for a game of chance |
AU2001241533A1 (en) | 2000-02-15 | 2001-08-27 | The Regents Of The University Of California | A universal vaccine and method for treating cancer employing telomerase reverse transcriptase |
US7262174B2 (en) | 2001-05-09 | 2007-08-28 | Geron Corporation | Treatment for wounds |
JP2002348474A (ja) | 2001-05-23 | 2002-12-04 | Dow Corning Toray Silicone Co Ltd | ポリオルガノシロキサンマイクロエマルジョン組成物および化粧料原料 |
AU2002363231A1 (en) | 2001-10-29 | 2003-05-12 | Baylor College Of Medicine | Human telomerase reverse transcriptase as a class-ii restricted tumor-associated antigen |
US7294708B2 (en) | 2002-05-31 | 2007-11-13 | Beijing Institute Of Biotechnology | Telomerase reverse transcriptase fragments and uses thereof |
KR100705868B1 (ko) | 2003-05-06 | 2007-04-10 | 후지 덴키 디바이스 테크놀로지 가부시키가이샤 | 반도체 장치 및 그 제조 방법 |
-
1997
- 1997-10-01 AT AT97307757T patent/ATE245194T1/de active
- 1997-10-01 EP EP97910785A patent/EP0954585B1/fr not_active Expired - Lifetime
- 1997-10-01 EP EP97307757A patent/EP0841396B2/fr not_active Expired - Lifetime
- 1997-10-01 JP JP51680298A patent/JP2001523947A/ja active Pending
- 1997-10-01 CA CA2645721A patent/CA2645721C/fr not_active Expired - Lifetime
- 1997-10-01 EA EA199900349A patent/EA199900349A1/ru unknown
- 1997-10-01 KR KR1019990702815A patent/KR20000048820A/ko not_active Application Discontinuation
- 1997-10-01 GB GB9720890.4A patent/GB2317891C/en not_active Expired - Lifetime
- 1997-10-01 CA CA2267664A patent/CA2267664C/fr not_active Expired - Lifetime
- 1997-10-01 DE DE69723531T patent/DE69723531T3/de not_active Expired - Lifetime
- 1997-10-01 JP JP51690998A patent/JP2001510985A/ja active Pending
- 1997-10-01 BR BR9712254-8A patent/BR9712254A/pt not_active IP Right Cessation
- 1997-10-01 DE DE69739497T patent/DE69739497D1/de not_active Expired - Lifetime
- 1997-10-01 JP JP28618297A patent/JP3869092B2/ja not_active Expired - Lifetime
- 1997-10-01 CN CN971802564A patent/CN1291231B/zh not_active Expired - Lifetime
- 1997-10-01 AU AU48036/97A patent/AU4803697A/en not_active Abandoned
- 1997-10-01 WO PCT/US1997/017885 patent/WO1998014593A2/fr not_active Application Discontinuation
- 1997-10-01 AT AT97910785T patent/ATE449851T1/de not_active IP Right Cessation
- 1997-10-01 ES ES97307757T patent/ES2205132T5/es not_active Expired - Lifetime
- 1997-10-01 EA EA199900355A patent/EA199900355A1/ru unknown
- 1997-10-01 EP EP97910737A patent/EP0932686A2/fr not_active Withdrawn
- 1997-10-01 DE DE69739675T patent/DE69739675D1/de not_active Expired - Lifetime
- 1997-10-01 CN CN201010150493.9A patent/CN102021153B/zh not_active Expired - Lifetime
- 1997-10-01 KR KR1019997002838A patent/KR100530483B1/ko not_active IP Right Cessation
- 1997-10-01 DE DE19743497A patent/DE19743497A1/de not_active Withdrawn
- 1997-10-01 BR BRPI9712254A patent/BRPI9712254B1/pt unknown
- 1997-10-01 BR BR9711844-3A patent/BR9711844A/pt unknown
- 1997-10-01 FR FR9712217A patent/FR2757177A1/fr active Pending
- 1997-10-01 NZ NZ334709A patent/NZ334709A/en not_active IP Right Cessation
- 1997-10-01 EP EP03075454A patent/EP1333094B1/fr not_active Expired - Lifetime
- 1997-10-01 AU AU48073/97A patent/AU734089B2/en not_active Expired
- 1997-10-01 EP EP20090176870 patent/EP2213740A1/fr not_active Withdrawn
- 1997-10-01 IL IL12922297A patent/IL129222A0/xx unknown
- 1997-10-01 CA CA002266752A patent/CA2266752A1/fr not_active Abandoned
- 1997-10-01 IL IL12910397A patent/IL129103A0/xx not_active IP Right Cessation
- 1997-10-01 SG SG200101834A patent/SG94355A1/en unknown
- 1997-10-01 GB GB9804859A patent/GB2321642B8/en not_active Expired - Lifetime
- 1997-10-01 WO PCT/US1997/017618 patent/WO1998014592A2/fr not_active Application Discontinuation
- 1997-10-01 DE DE0841396T patent/DE841396T1/de active Pending
- 1997-10-01 CN CN97199534A patent/CN1254376A/zh active Pending
- 1997-10-01 AT AT03075454T patent/ATE552341T1/de active
- 1997-10-01 EP EP06117664A patent/EP1783139B8/fr not_active Expired - Lifetime
- 1997-11-19 US US08/974,549 patent/US6166178A/en not_active Expired - Lifetime
-
1998
- 1998-10-15 JP JP32016998A patent/JP4070331B2/ja not_active Expired - Lifetime
-
1999
- 1999-02-19 JP JP11042410A patent/JPH11313689A/ja active Pending
- 1999-03-24 FI FI990655A patent/FI990655A0/fi unknown
- 1999-03-31 NO NO19991588A patent/NO319982B1/no not_active IP Right Cessation
-
2000
- 2000-07-27 JP JP2000227474A patent/JP2001081042A/ja not_active Withdrawn
- 2000-11-22 US US09/721,456 patent/US6617110B1/en not_active Expired - Lifetime
- 2000-11-22 US US09/721,477 patent/US7517971B1/en not_active Expired - Fee Related
-
2005
- 2005-06-24 NO NO20053120A patent/NO332085B1/no unknown
-
2007
- 2007-08-20 US US11/894,600 patent/US8222392B2/en not_active Expired - Fee Related
-
2008
- 2008-07-28 JP JP2008194208A patent/JP4852576B2/ja not_active Expired - Lifetime
-
2011
- 2011-10-18 HK HK11111117.2A patent/HK1156967A1/zh not_active IP Right Cessation
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996001835A1 (fr) * | 1994-07-07 | 1996-01-25 | Geron Corporation | Telomerase mammifere |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2317891B (en) | Human Telomerase Catalytic Subunit | |
ATE410446T1 (de) | Zusammensetzungen zur behandlung und diagnose von eierstockkrebs | |
TR199901971T2 (xx) | Bir resept�re ba�lanan peptidler ve bile�ikler. | |
IL153052A0 (en) | Nrg-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods | |
NZ512247A (en) | Compositions and methods for therapy and diagnosis of ovarian cancer | |
HK1145692A1 (zh) | 人血管生成素- 的特異結合劑 | |
DE60019273D1 (de) | Verwendung von casb616 polypeptiden und polynukleotiden zur krebsbehandlung | |
WO1999033869A3 (fr) | Composes destines a l'immunotherapie et au diagnostic du cancer du sein, et leur mode d'utilisation | |
RU2001104349A (ru) | Композиции и способы для терапии и диагностики рака предстательной железы | |
WO1998059040A3 (fr) | Sous-unite de telomerase catalytique humaine et son utilisation therapeutique et diagnostique | |
WO2001018046A3 (fr) | Sequences de tumeurs ovariennes et procedes d'utilisation correspondants | |
WO2004047757A3 (fr) | Diagnostic et traitement des cancers hematopoietiques | |
UA72875C2 (uk) | БІЛКИ, ЯКІ ЗВ'ЯЗУЮТЬСЯ З <font face="Symbol">b</font>-АМІЛОЇДНИМ ПЕПТИДОМ ТА ПОЛІНУКЛЕОТИДИ, ЩО ЇХ КОДУЮТЬ | |
DE69831223D1 (de) | Gefriergetrocknete zusammensetzung des menschlichen,morphogenen knochenproteins mp52 | |
WO1998024896A3 (fr) | Muteines de la proteine de l'obesite | |
ATE435284T1 (de) | Zusammensetzungen und verfahren zur therapie und diagnose von lungenkrebs | |
ATE542900T1 (de) | Icbp90-polypeptide, polypeptidfragmente davon, die dafür kodierenden polynukleotide, und ihre verwendung zur behandlung und diagnose von krebs | |
IT1270614B (it) | Proteine ad attivita' antitumorale da organi di mammiferi |